IASO Bio Announces Approval of New Drug Application for Equecabtagene Autoleucel by the Macau Pharmaceutical Administration Bureau
Yanchang Petroleum International Announces 2024 Annual Results
Mirae Asset Debuts Global X FTSE Greater China ETF (3470) with Cost-Competitive Access to Regional Markets
Fangzhou Inc. Named Among Guangzhou's Top AI Innovators for Intelligent Healthcare Platform
Gravity Officially Launches Mobile Version of Roguelike Deck-Building Adventure Game 'Shambles: Sons of the Apocalypse' Globally
Neutech Group Limited Announces 2024 Annual Results
JelloX Research Collaborations Further Demonstrate Promise of 3D Pathology
Vixtel and EE Group Australia Join Forces to Expand into the Australian AI Perception Intelligence Market
